HomeCompareVYNT vs DIVO

VYNT vs DIVO: Dividend Comparison 2026

VYNT yields 1030.93% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VYNT wins by $24587954.16M in total portfolio value
10 years
VYNT
VYNT
● Live price
1030.93%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24587954.20M
Annual income
$20,648,027,961,236.51
Full VYNT calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — VYNT vs DIVO

📍 VYNT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVYNTDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VYNT + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VYNT pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VYNT
Annual income on $10K today (after 15% tax)
$87,628.87/yr
After 10yr DRIP, annual income (after tax)
$17,550,823,767,051.04/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, VYNT beats the other by $17,550,823,766,193.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VYNT + DIVO for your $10,000?

VYNT: 50%DIVO: 50%
100% DIVO50/50100% VYNT
Portfolio after 10yr
$12293977.11M
Annual income
$10,324,013,981,122.49/yr
Blended yield
83.98%
📊

Analyst Conviction Gap

Where Wall Street is split right now

VYNT
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-12.0
Piotroski
2/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VYNT buys
0
DIVO buys
0
No recent congressional trades found for VYNT or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVYNTDIVO
Forward yield1030.93%6.62%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$24587954.20M$31.0K
Annual income after 10y$20,648,027,961,236.51$1,008.47
Total dividends collected$24288183.04M$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: VYNT vs DIVO ($10,000, DRIP)

YearVYNT PortfolioVYNT Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$113,793$103,092.78$11,362$661.96+$102.4KVYNT
2$1,218,133$1,096,375.21$12,860$702.91+$1.21MVYNT
3$12,272,114$10,968,711.02$14,504$743.56+$12.26MVYNT
4$116,406,425$103,275,262.74$16,303$783.73+$116.39MVYNT
5$1,040,079,657$915,524,782.99$18,268$823.31+$1040.06MVYNT
6$8,757,858,648$7,644,973,414.41$20,408$862.17+$8757.84MVYNT
7$69,533,084,085$60,162,175,331.66$22,737$900.20+$69533.06MVYNT
8$520,809,783,127$446,409,383,156.47$25,266$937.31+$520809.76MVYNT
9$3,682,174,050,693$3,124,907,582,747.50$28,008$973.42+$3682174.02MVYNT
10$24,587,954,195,479$20,648,027,961,236.51$30,977$1,008.47+$24587954.16MVYNT

VYNT vs DIVO: Complete Analysis 2026

VYNTStock

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.

Full VYNT Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this VYNT vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VYNT vs SCHDVYNT vs JEPIVYNT vs OVYNT vs KOVYNT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.